Tenderwize
Back to tender search

Open House Drug Discount Contracts for the Active Ingredient Ibuprofen, ATC M01AE01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 227 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ibuprofen, ATC M01AE01

80/100

Opportunity Score

PromisingLow complexity
SuppliesOpen
Why this score?

Opportunity

80 / 100

Complexity

20 / 100

Risk factors

The buyer reserves the right to replace open-house contracts with exclusive discount contracts via EU-wide tender at an...

Structured data flags EU funding (isEuFunded: true), but the XML notice explicitly states 'no-eu-funds'. This inconsist...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Strong opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Conclusion of non-exclusive discount contracts for Ibuprofen (ATC M01AE01) drugs under SGB V.
  • Open house model: all interested pharmaceutical companies can join without selection.
Show full summary

The AOK Rheinland-Pfalz/Saarland offers non-exclusive drug discount contracts (Open House) for the active ingredient Ibuprofen (ATC M01AE01) under German social law (SGB V). All pharmaceutical companies with authorized and marketable Ibuprofen products in Germany can join without selection. Contracts have a maximum duration of 24 months, starting from June 2025. The notice is published voluntarily and does not constitute an EU procurement. Paper-based submission is required; electronic submission is not allowed. The tender has no estimated value and no specific award criteria. Note: The structured data indicates EU funding, but the XML notice explicitly states no EU funding. This analysis is based on the structured data and XML notice only; no separate procurement documents were analyzed.

Risks

The buyer reserves the right to replace open-house contracts with exclusive discount contracts via EU-wide tender at an...

Structured data flags EU funding (isEuFunded: true), but the XML notice explicitly states 'no-eu-funds'. This inconsist...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

  • Only authorized and marketable drugs in Germany (proof via Lauer-Taxe listing or AMIce database) are eligible.

Administrative

  • Paper-based submission required; electronic submission is not allowed.
  • Submission in German language only (as per notice language).

Award Criteria

Lot 1

No award criteria; this is an open-house model with no selection.

Buyer

Lots (1)

LOT-0001

Open House Drug Discount Contracts for the Active Ingredient Ibuprofen, ATC M01AE01

Non-exclusive discount contracts for Ibuprofen drugs under German SGB V. Open to all pharmaceutical companies with authorized and marketable Ibuprofen products. Contracts last up to 24 months, with enrollment possible at the start of each month. All contracts end simultaneously 24 months after the earliest contract start date (June 2025). The buyer may replace open-house contracts with exclusive contracts via tender at any time.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Award Criteria

No award criteria; this is an open-house model with no selection.

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
238514-2025

Documents (1)

Similar tenders